Sanofi-Aventis has entered into a definitve agreement to buy Genzyme for $20.1bn in cash, in addition to future payments based on the performance of Genzyme’s experimental multiple sclerosis drug (alemtuzumab MS).
LGC adds PRIMACYT in-vitro products, services for drug discovery research
LGC Standards, an England-based scientific company which provides analytical, forensic and diagnostic services and reference standards, has added the PRIMACYT range of in-vitro products and services to its life science research and drug discovery products portfolio.
BARDA awards Aeolus, Biotest contracts to develop drugs against acute radiation syndrome
The US Department of Health and Human Services’ Biomedical Advanced Research and Development Authority (BARDA) has awarded contracts to Aeolus Pharmaceuticals and Biotest towards the development of drugs to treat skin and lung injuries associated with acute radiation syndrome (ARS) that results from a nuclear blast.
Astellas, Medivation release prostate cancer drug positive data
Astellas Pharma and Medivation have released positive, new, long-term follow-up data from the Phase 1-2 trial of novel, triple-acting, oral androgen receptor antagonist MDV3100 in patients with advanced prostate cancer.
Daiichi Sankyo acquires Amcor packaging, manufacturing facility in US
Daiichi Sankyo has acquired global packaging manufacturer Amcor’s 140,000 square foot facility in Bethlehem Township, Pennsylvania, for $10.25m.
Affymetrix launches NG Class detergents for better protein analysis
California-based Affymetrix has launched Anatrace brand of Neopentyl Glycol (NG) Class Detergents which discernibly advances integral membrane proteins (IMPs) studies.
Jomaa Pharma, MMV to jointly develop novel malaria treatment
Germany-based Jomaa Pharma, a biopharmaceutical company dedicated to malaria chemotherapy, and Medicines for Malaria Venture (MMV), a not-for-profit research foundation, , have signed a memorandum of understanding (MoU) to jointly develop fosmidomycin as part of non-artemisinin based combination therapy (NACT) to treat acute Plasmodium falciparum malaria.
Marina Biotech presents integrated technology platform
Marina Biotech, a RNAi-based drug discovery and development company, presented and described their integrated technology platform for the discovery of multiple oligonucleotide-based drugs.
Dutch bioscience firm Pantarhei looks to buy Merck Netherlands unit
Pantarhei, a Denmark-based bioscience company, is planning to bid for the bulk of Merck’s Netherlands-based bioscience research unit Organon, which Merck acquired in its merger with Schering-Plough.
Special thanks to www.IndianPharmacy.org an indian pharmacy who provides me the list of generic drugs and data. Indian Pharmacy online supplies quality generic drugs, free prescription and she can ship the good worldwide.
Related posts:
